nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—Thrombosis—Mechlorethamine—lymphatic system cancer	0.0352	0.0352	CcSEcCtD
Hydroxocobalamin—Chromaturia—Mitoxantrone—lymphatic system cancer	0.0269	0.0269	CcSEcCtD
Hydroxocobalamin—Extravasation—Teniposide—lymphatic system cancer	0.021	0.021	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.0189	0.0189	CcSEcCtD
Hydroxocobalamin—Phlebitis—Teniposide—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Hydroxocobalamin—Thrombosis—Carmustine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Hydroxocobalamin—Phlebitis—Fludarabine—lymphatic system cancer	0.0136	0.0136	CcSEcCtD
Hydroxocobalamin—Extravasation—Bleomycin—lymphatic system cancer	0.0135	0.0135	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Fludarabine—lymphatic system cancer	0.0129	0.0129	CcSEcCtD
Hydroxocobalamin—Extravasation—Carmustine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Hydroxocobalamin—Extravasation—Vincristine—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Hydroxocobalamin—Extravasation—Mitoxantrone—lymphatic system cancer	0.011	0.011	CcSEcCtD
Hydroxocobalamin—Injection site reaction—Carmustine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Hydroxocobalamin—Dysphagia—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Hydroxocobalamin—Phlebitis—Bleomycin—lymphatic system cancer	0.00996	0.00996	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0092	0.0092	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00888	0.00888	CcSEcCtD
Hydroxocobalamin—Infection—Mechlorethamine—lymphatic system cancer	0.00882	0.00882	CcSEcCtD
Hydroxocobalamin—Phlebitis—Carmustine—lymphatic system cancer	0.00869	0.00869	CcSEcCtD
Hydroxocobalamin—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00862	0.00862	CcSEcCtD
Hydroxocobalamin—Swelling—Carmustine—lymphatic system cancer	0.00849	0.00849	CcSEcCtD
Hydroxocobalamin—Chills—Teniposide—lymphatic system cancer	0.00827	0.00827	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Teniposide—lymphatic system cancer	0.00823	0.00823	CcSEcCtD
Hydroxocobalamin—Phlebitis—Mitoxantrone—lymphatic system cancer	0.00808	0.00808	CcSEcCtD
Hydroxocobalamin—Swelling—Mitoxantrone—lymphatic system cancer	0.00789	0.00789	CcSEcCtD
Hydroxocobalamin—Cardiac failure congestive—Mitoxantrone—lymphatic system cancer	0.00768	0.00768	CcSEcCtD
Hydroxocobalamin—Folliculitis—Methotrexate—lymphatic system cancer	0.0076	0.0076	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Carmustine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Hydroxocobalamin—Agitation—Teniposide—lymphatic system cancer	0.00737	0.00737	CcSEcCtD
Hydroxocobalamin—Chills—Fludarabine—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Fludarabine—lymphatic system cancer	0.00723	0.00723	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Vincristine—lymphatic system cancer	0.00718	0.00718	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Mitoxantrone—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Hydroxocobalamin—Chest pain—Teniposide—lymphatic system cancer	0.00683	0.00683	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Carmustine—lymphatic system cancer	0.00682	0.00682	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Vincristine—lymphatic system cancer	0.0068	0.0068	CcSEcCtD
Hydroxocobalamin—Lung disorder—Methotrexate—lymphatic system cancer	0.00675	0.00675	CcSEcCtD
Hydroxocobalamin—Oedema—Teniposide—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Hydroxocobalamin—Infection—Teniposide—lymphatic system cancer	0.0065	0.0065	CcSEcCtD
Hydroxocobalamin—Agitation—Fludarabine—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Hydroxocobalamin—Dysphagia—Carmustine—lymphatic system cancer	0.00647	0.00647	CcSEcCtD
Hydroxocobalamin—Tachycardia—Teniposide—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Hydroxocobalamin—Malaise—Fludarabine—lymphatic system cancer	0.00636	0.00636	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Mitoxantrone—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Hydroxocobalamin—Pruritus—Mechlorethamine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Hydroxocobalamin—Pleural effusion—Methotrexate—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00607	0.00607	CcSEcCtD
Hydroxocobalamin—Discomfort—Fludarabine—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Teniposide—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Hydroxocobalamin—Oedema—Fludarabine—lymphatic system cancer	0.00575	0.00575	CcSEcCtD
Hydroxocobalamin—Infection—Fludarabine—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Hydroxocobalamin—Rash—Mechlorethamine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Hydroxocobalamin—Extravasation—Methotrexate—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Hydroxocobalamin—Chills—Bleomycin—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Hydroxocobalamin—Nausea—Mechlorethamine—lymphatic system cancer	0.00527	0.00527	CcSEcCtD
Hydroxocobalamin—Urticaria—Teniposide—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Teniposide—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Hydroxocobalamin—Erythema—Bleomycin—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Fludarabine—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Carmustine—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00497	0.00497	CcSEcCtD
Hydroxocobalamin—Pain—Fludarabine—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Vincristine—lymphatic system cancer	0.00485	0.00485	CcSEcCtD
Hydroxocobalamin—Eye disorder—Carmustine—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Hydroxocobalamin—Malaise—Bleomycin—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Hydroxocobalamin—Pruritus—Teniposide—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Carmustine—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Vincristine—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Hydroxocobalamin—Mental disorder—Carmustine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Hydroxocobalamin—Erythema—Carmustine—lymphatic system cancer	0.00451	0.00451	CcSEcCtD
Hydroxocobalamin—Angiopathy—Vincristine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Teniposide—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Hydroxocobalamin—Chest pain—Bleomycin—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Hydroxocobalamin—Discomfort—Bleomycin—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Hydroxocobalamin—Mental disorder—Vincristine—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Hydroxocobalamin—Chills—Mitoxantrone—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00425	0.00425	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Hydroxocobalamin—Oedema—Bleomycin—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Hydroxocobalamin—Erythema—Mitoxantrone—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Hydroxocobalamin—Infection—Bleomycin—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Hydroxocobalamin—Agitation—Carmustine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Hydroxocobalamin—Rash—Teniposide—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Hydroxocobalamin—Dermatitis—Teniposide—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Hydroxocobalamin—Headache—Teniposide—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Hydroxocobalamin—Pruritus—Fludarabine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Hydroxocobalamin—Agitation—Vincristine—lymphatic system cancer	0.00396	0.00396	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Hydroxocobalamin—Nausea—Teniposide—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Hydroxocobalamin—Chest pain—Carmustine—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Hydroxocobalamin—Malaise—Mitoxantrone—lymphatic system cancer	0.00378	0.00378	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Hydroxocobalamin—Oedema—Carmustine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Hydroxocobalamin—Infection—Carmustine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Hydroxocobalamin—Rash—Fludarabine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Hydroxocobalamin—Dermatitis—Fludarabine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Hydroxocobalamin—Pain—Bleomycin—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Hydroxocobalamin—Headache—Fludarabine—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Hydroxocobalamin—Tachycardia—Carmustine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Hydroxocobalamin—Chest pain—Mitoxantrone—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Hydroxocobalamin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00353	0.00353	CcSEcCtD
Hydroxocobalamin—Oedema—Vincristine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00351	0.00351	CcSEcCtD
Hydroxocobalamin—Infection—Vincristine—lymphatic system cancer	0.00349	0.00349	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Hydroxocobalamin—Oedema—Mitoxantrone—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Hydroxocobalamin—Nausea—Fludarabine—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Hydroxocobalamin—Infection—Mitoxantrone—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Hydroxocobalamin—Urticaria—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Hydroxocobalamin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00334	0.00334	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Hydroxocobalamin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Carmustine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00318	0.00318	CcSEcCtD
Hydroxocobalamin—Pain—Carmustine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Hydroxocobalamin—Pain—Vincristine—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Hydroxocobalamin—Pruritus—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Hydroxocobalamin—Pain—Mitoxantrone—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Carmustine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Hydroxocobalamin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Hydroxocobalamin—Rash—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Hydroxocobalamin—Dermatitis—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Vincristine—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Carmustine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Hydroxocobalamin—Nausea—Bleomycin—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Hydroxocobalamin—Dizziness—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Vincristine—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Methotrexate—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Hydroxocobalamin—Dizziness—Vincristine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Hydroxocobalamin—Rash—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Hydroxocobalamin—Dermatitis—Carmustine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Hydroxocobalamin—Headache—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Hydroxocobalamin—Eye disorder—Methotrexate—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Hydroxocobalamin—Rash—Vincristine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Hydroxocobalamin—Dermatitis—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Hydroxocobalamin—Headache—Vincristine—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Hydroxocobalamin—Nausea—Carmustine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Hydroxocobalamin—Angiopathy—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Methotrexate—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Hydroxocobalamin—Rash—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Hydroxocobalamin—Chills—Methotrexate—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Hydroxocobalamin—Headache—Mitoxantrone—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Hydroxocobalamin—Mental disorder—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Hydroxocobalamin—Erythema—Methotrexate—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Hydroxocobalamin—Nausea—Vincristine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Hydroxocobalamin—Nausea—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Hydroxocobalamin—Malaise—Methotrexate—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Hydroxocobalamin—Chest pain—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Hydroxocobalamin—Discomfort—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Hydroxocobalamin—Infection—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Hydroxocobalamin—Skin disorder—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Hydroxocobalamin—Pain—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Hydroxocobalamin—Urticaria—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Hydroxocobalamin—Pruritus—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Hydroxocobalamin—Dizziness—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Hydroxocobalamin—Rash—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Hydroxocobalamin—Dermatitis—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Hydroxocobalamin—Headache—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Hydroxocobalamin—Nausea—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
